THE EFFECT OF COGNITIVE THERAPY SOFTWARE 'NDTX-01' IN PATIENTS WITH SOCIAL COMMUNICATION DISORDERS OR ASD: PROSPECTIVE, COMPARED, OPEN, RANDOMIZED PILOT STUDY

被引：0

作者：

Choi, Tae Young ^{[1
]}

Moon, Jung Yeon ^{[1
]}

Jeong, Hyanghee ^{[1
]}

Kim, Jun Won ^{[1
]}

Cho, Sungja ^{[1
]}

Yoo, Jae Hyun ^{[1
]}

Joung, Yoo-Sook ^{[1
]}

机构：

[1] Catholic Univ Korea, Seoul, South Korea

来源：

JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY | 2024年 / 63卷 / 10期

关键词：

D O I：

10.1016/j.jaac.2024.08.365

中图分类号：

B844 [发展心理学（人类心理学）];

学科分类号：

040202 ;

摘要：

5.44

引用

页码：S269 / S270

页数：2

共 29 条

[21] Study protocol for RUFUS-A randomized mixed methods pilot clinical trial investigating the relevance and feasibility of rumination-focused cognitive behavioral therapy in the treatment of patients with emergent psychosis spectrum disorders
Clemmensen, Lars
Lund, Christin Nymann
Andresen, Birgitte S.
Midtgaard, Julie
Glenthoj, Louise Birkedal
PLOS ONE, 2024, 19 (01):
[22] The efficacy of rebamipide add-on therapy in arthritic patients with COX-2 selective inhibitor-related gastrointestinal events: a prospective, randomized, open-label blinded-endpoint pilot study by the GLORIA study group
Hasegawa, Masahiro
Horiki, Noriyuki
Tanaka, Kyosuke
Wakabayashi, Hiroki
Tano, Shunsuke
Katsurahara, Masaki
Uchida, Atsumasa
Takei, Yoshiyuki
Sudo, Akihiro
MODERN RHEUMATOLOGY, 2013, 23 (06) : 1172 - 1178
[23] Effect of mobile-based cognitive behavior therapy (CBT) on lowering of blood lipid levels in atherosclerotic cardiovascular disease (ASCVD) patients: study protocol for a multicenter, prospective, randomized controlled trial
Xu-Lin Hong
Yi Luan
Hong-Ying Liu
Wen-Bin Zhang
Trials, 23
[24] Effect of mobile-based cognitive behavior therapy (CBT) on lowering of blood lipid levels in atherosclerotic cardiovascular disease (ASCVD) patients: study protocol for a multicenter, prospective, randomized controlled trial
Hong, Xu-Lin
Luan, Yi
Liu, Hong-Ying
Zhang, Wen-Bin
TRIALS, 2022, 23 (01)
[25] Triple Antiplatelet Therapy (Aspirin, Clopidogrel, Cilostazol) Loading Followed by Maintenance Reduces Greater Serum Level of Scd4ol and Tnf-a Than Dual Antiplatelet Therapy in Patients With Acute Myocardial Infarction Undergoing Pci: Two-Center, Prospective, Open Label, Randomized, Pilot Study
Park, Mahn Won
Her, Sung-Ho
Cho, Jung-sun
Kim, Chan Joon
Park, Gyung-Min
Chang, Kiyuk
Seung, Ki-Bae
Choo, Eun-Ho
Kim, Jin-Jin
Kim, Jae-Kyung
Yim, Sang-Hyeon
Seo, Suk-Min
Hwang, Byung-Hee
Kim, Pum-Jun
Chung, Wook-Sung
CIRCULATION, 2013, 128 (22)
[26] I-ADD Study: Assessment of Efficacy and Safety Profile of Irbesartan/Amlodipine Fixed-Dose Combination Therapy Compared With Irbesartan Monotherapy in Hypertensive Patients Uncontrolled With Irbesartan 150 mg Monotherapy: A Multicenter, Phase III, Prospective, Randomized, Open-Label With Blinded End Point Evaluation Study
Bobrie, Guillaume
CLINICAL THERAPEUTICS, 2012, 34 (08) : 1720 - 1734
[27] I-COMBINE Study: Assessment of Efficacy and Safety Profile of Irbesartan/Amlodipine Fixed-Dose Combination Therapy Compared With Amlodipine Monotherapy in Hypertensive Patients Uncontrolled With Amlodipine 5 mg Monotherapy: A Multicenter, Phase III, Prospective, Randomized, Open-Label With Blinded-End Point Evaluation Study
Bobrie, Guillaume
CLINICAL THERAPEUTICS, 2012, 34 (08) : 1705 - 1719
[28] A Prospective, Randomized, Double-Blinded, Double-Dummy Pilot Study to Assess the Preemptive Effect of Triple Therapy with Aprepitant, Dexamethasone, and Promethazine versus Ondansetron, Dexamethasone and Promethazine on Reducing the Incidence of Postoperative Nausea and Vomiting Experienced by Patients Undergoing Craniotomy Under General Anesthesia
Bergese, Sergio Daniel
Puente, Erika G.
Antor, Maria A.
Viloria, Adolfo L.
Yildiz, Vedat
Kumar, Nicolas Alexander
Uribe, Alberto A.
FRONTIERS IN MEDICINE, 2016, 3
[29] Triple-Arm, Prospective, Multicentre, Randomized, Open-Label, Active-Controlled Study to Assess Effect on FDC of Teneligliptin 20 mg + Dapagliflozin 10 mg Compared with FDC of Sitagliptin 100 mg + Dapagliflozin 10 mg and FDC of Linagliptin 5 mg+ Empagliflozin 25 mg on 24-Hour Glucose Profile Assessed by Continuous Glucose Monitoring (CGM) in Indian Patients of Type 2 Diabetes Mellitus In Real-World Setting (AMPLIFY-TIR STUDY)-Interim Report
Barkate, Hanmant V.
Petare, Anup U.
Bhushan, Sumit
Choudhari, Sanjay Y.
Brid, Manasi
Patil, Saiprasad
DIABETES, 2024, 73

← 1 2 3 →